Isabelle Breier

• Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX) in its US$10 billion acquisition of Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a commercial-stage biopharmaceutical company focused on endocrine diseases.
• Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, in its acquisition by Angelini Pharma S.p.A for US$4.1 billion.
• Kinderhook Industries, LLC in its US$1.1 billion acquisition of Enhabit, Inc. (NYSE: EHAB), a home health and hospice provider.
• Kingswood Capital Management, LP in its acquisition of Drive DeVilbiss Healthcare, a durable medical equipment company.
• Dental Care Alliance, one of the country’s largest dental support organizations, in a restructuring transaction.
• Corza Medical, a GTCR, LLC-backed global medical technology company, on its agreement to sell its biosurgery business, including the TachoSil® product portfolio, to EQT Group. 
• Model N, Inc., a revenue optimization and compliance platform for life sciences companies, in its acquisition of Kalderos, a technology company that provides an intelligence platform for pharmaceutical manufacturers participating in 340B drug discount programs.
• Altaris Capital Partners, LLC in its acquisition of Tegria, a healthcare consulting company.
• Medical Solutions, one of the nation’s leading healthcare workforce solutions partners, in a financing and exchange transaction.
• Noramco Group, a specialty active pharmaceutical ingredient development and manufacturing company, in SK Capital Partners, LP’s sale of Noramco Group to Siegfried Holding AG.
• A healthcare information technology company in its acquisition of a revenue cycle management company.
• A private equity client in its acquisition of a retiree benefits management platform.
• Various private equity clients in their sales of a health benefits provider, an infusion therapy provider, and an employee benefits company.

Includes matters handled at Dechert or prior to joining the firm.